Research Article
Effect of Prophylactic Central Lymph Node Dissection on Locoregional Recurrence in Patients with Papillary Thyroid Microcarcinoma
Table 1
Baseline characteristics of patients (N = 1584).
| | N (%) |
| Age | 46.99 ± 11.66 | Diameter | 0.59 ± 0.24 | Gender | Males | 339 (21.4%) | Females | 1245 (78.6%) | LND | No | 100 (6.3%) | PCLND | 1484 (93.7%) | Surgery | TT | 693 (43.8%) | ST | 176 (11.1%) | LT | 715 (45.1%) | Multifocality | No | 1181 (74.6%) | Yes | 403 (25.4%) | Capsule invasion | No | 1084 (68.4%) | Yes | 500 (31.6%) | ETE | | No | 1548 (97.7%) | Yes | 36 (2.3%) | Occult central lymph node metastases | No | 1109 (70.0%) | Yes | 475 (30.0%) |
|
|
LND, lymph node dissection; PCLND, prophylactic central lymph node dissection; TT, total thyroidectomy; ST, subtotal thyroidectomy; TL, thyroid lobectomy; ETE, extrathyroidal extension.
|